3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:百万円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

2,767

4,008

受取手形及び売掛金

2,100

1,804

電子記録債権

531

464

商品及び製品

2,193

2,112

仕掛品

621

442

原材料及び貯蔵品

726

776

その他

108

114

貸倒引当金

3

3

流動資産合計

9,045

9,721

固定資産

 

 

有形固定資産

 

 

建物及び構築物(純額)

501

663

機械装置及び運搬具(純額)

371

675

土地

636

694

建設仮勘定

111

1,166

その他(純額)

127

170

有形固定資産合計

1,748

3,370

無形固定資産

 

 

リース資産

130

99

その他

13

17

無形固定資産合計

143

116

投資その他の資産

 

 

投資有価証券

1,520

1,809

繰延税金資産

109

221

その他

78

68

投資その他の資産合計

1,708

2,099

固定資産合計

3,600

5,587

資産合計

12,646

15,308

 

 

 

 

(単位:百万円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

流動負債

 

 

買掛金

1,418

1,450

電子記録債務

83

1年内返済予定の長期借入金

100

未払法人税等

66

204

賞与引当金

136

230

その他

568

826

流動負債合計

2,190

2,895

固定負債

 

 

長期借入金

716

退職給付に係る負債

124

繰延税金負債

135

255

その他

14

13

固定負債合計

150

1,110

負債合計

2,340

4,006

純資産の部

 

 

株主資本

 

 

資本金

300

300

資本剰余金

3,453

3,438

利益剰余金

6,513

7,213

自己株式

377

327

株主資本合計

9,888

10,624

その他の包括利益累計額

 

 

その他有価証券評価差額金

403

646

繰延ヘッジ損益

0

為替換算調整勘定

12

30

その他の包括利益累計額合計

416

676

非支配株主持分

0

純資産合計

10,305

11,301

負債純資産合計

12,646

15,308

 

E3676943600株式会社マナック・ケミカル・パートナーズMANAC Chemical Partners Co.,Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse436002026-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002026-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002026-03-31jpcrp_cor:ReconcilingItemsMember436002025-04-012026-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002025-04-012026-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002025-04-012026-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember436002025-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002025-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002025-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002025-03-31jpcrp_cor:ReconcilingItemsMember436002026-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002025-03-31jppfs_cor:RetainedEarningsMember436002025-03-31jppfs_cor:CapitalSurplusMember436002025-03-31jppfs_cor:CapitalStockMember436002026-05-14436002026-03-31436002025-04-012026-03-31436002025-03-31436002024-04-012025-03-31436002024-03-31436002024-03-31jppfs_cor:ShareholdersEquityMember436002024-03-31jppfs_cor:CapitalStockMember436002024-03-31jppfs_cor:CapitalSurplusMember436002024-03-31jppfs_cor:RetainedEarningsMember436002024-03-31jppfs_cor:TreasuryStockMember436002024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002024-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002024-04-012025-03-31jppfs_cor:ShareholdersEquityMember436002024-04-012025-03-31jppfs_cor:CapitalStockMember436002024-04-012025-03-31jppfs_cor:CapitalSurplusMember436002024-04-012025-03-31jppfs_cor:RetainedEarningsMember436002024-04-012025-03-31jppfs_cor:TreasuryStockMember436002024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002024-04-012025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember436002026-03-31jpcrp_cor:ReportableSegmentsMember436002025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember436002025-03-31jpcrp_cor:ReportableSegmentsMember436002024-04-012025-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002024-04-012025-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002024-04-012025-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember436002026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002026-03-31jppfs_cor:ShareholdersEquityMember436002026-03-31jppfs_cor:TreasuryStockMember436002026-03-31jppfs_cor:RetainedEarningsMember436002026-03-31jppfs_cor:CapitalSurplusMember436002026-03-31jppfs_cor:CapitalStockMember436002025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002025-04-012026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002025-04-012026-03-31jppfs_cor:ShareholdersEquityMember436002025-04-012026-03-31jppfs_cor:TreasuryStockMember436002025-04-012026-03-31jppfs_cor:RetainedEarningsMember436002025-04-012026-03-31jppfs_cor:CapitalSurplusMember436002025-04-012026-03-31jppfs_cor:CapitalStockMember436002025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002025-03-31jppfs_cor:ShareholdersEquityMember436002025-03-31jppfs_cor:TreasuryStockMember436002026-03-31jppfs_cor:NonControllingInterestsMember436002025-04-012026-03-31jppfs_cor:NonControllingInterestsMember436002025-03-31jppfs_cor:NonControllingInterestsMemberiso4217:JPYxbrli:pure